Fujifilm Biotechnologies has appointed Christiane Bardroff as Chief Business Officer (CBO), effective June 1, 2026.

BioDuro, a global CRDMO, has appointed Andrew Thomas, Ph.D., and Stevan Djuric, Ph.D., as scientific advisors.

SK pharmteco has announced the successful CGMP qualification of its manufacturing facility in Corbeil-Essonnes, France.

Trenchant BioSystems Inc. and Invetech have entered into a strategic alliance focused on the continued development of Trenchant’s fully automated AutoCell Platform.

Coriolis Pharma has opened a new U.S. headquarters and laboratory at the Alexandria Center for Advanced Technologies in North Carolina’s Research Triangle Park.

Agilent Technologies is launching Agilent Advanced Therapeutics, a unified CDMO solution integrating capabilities in Canada and the U.S.

Bespak is increasing pressurized metered dose inhaler manufacturing capacity to support Chiesi Group’s Carbon Minimal Inhaler (CMI) program.

Lyocontract and its partner Syntegon recently held a groundbreaking ceremony for a 50-million-euro ($57.6 million) production expansion in Germany. “With the groundbreaking ceremony, we are paving the ...

New biosimilar development, manufacturing and supply unit will be headed by Armin Metzger.

XCells Biotechnologies USA Inc. has delivered over 500 characterized induced pluripotent stem cell lines as part of a multi-year collaboration with a global biotechnology company.

Lundbeck has named Markus Kede Senior Vice President and Chief AI Officer. He is currently SVP, Finance & Business Planning for Lundbeck US.

Abselion, based in Cambridge, UK, is establishing a U.S. subsidiary at The Engine, located in Cambridge, Massachusetts.